🇺🇸 FDA
Patent

US 11154572

Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 11154572 (Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type) held by The Board of Regents of the University of Texas System expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K2300/00